The Administrative Core A, led by the Project Director, Dr. Richard Wyatt, will provide general management and administrative support for all Projects 1-4 and Core B under the HIVRAD POl. Additionally, this Core will coordinate an administrative plan to maintain clear lines of communication with investigators and collaborators within the bounds ofthe HIVRAD. Furthermore, communication with advisory board members and interactions with external researchers with interests in the HlV-1 Env-based vaccines and the analysis of B cell responses elicited of selected HIV-1 envelope glycoproteins candidates will be facilitated.
The first Aim will be to establish a project management plan designed by the Program Director with the goal to ensure the success ofthe HIVRAD through the several steps including a) continuous monitoring ofthe scientific progress of each component ofthe program, b) encouraging and leading internal communications among the individual investigators at each institution c) informing the appropriate officials at NIH of progress via teleconferences or email summaries d) provide fiscal review to ensure that all financial resources are appropriately utilized and e) initiating collaborations with investigators not currently part of this program.
The second Aim of this Core will be to form of a Scientific Advisory Board (SAB) and schedule annual meetings to evaluate progress and success of this HIVRAD program project.
This Core will oversee the coordination of all the Projects and Cores designed to elicit broadly neutralizing antibodies to the human pathogen HIV-1 toward the goal of a broadly effective vaccine. Thereby, this Core will have a direct impact on the improvement of human public health.
|Sheng, Zizhang; Schramm, Chaim A; Connors, Mark et al. (2016) Effects of Darwinian Selection and Mutability on Rate of Broadly Neutralizing Antibody Evolution during HIV-1 Infection. PLoS Comput Biol 12:e1004940|
|Guenaga, Javier; Dubrovskaya, Viktoriya; de Val, Natalia et al. (2016) Structure-Guided Redesign Increases the Propensity of HIV Env To Generate Highly Stable Soluble Trimers. J Virol 90:2806-17|
|Bonsignori, Mattia; Zhou, Tongqing; Sheng, Zizhang et al. (2016) Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody. Cell 165:449-63|
|Tian, Ming; Cheng, Cheng; Chen, Xuejun et al. (2016) Induction of HIV Neutralizing Antibody Lineages in Mice with Diverse Precursor Repertoires. Cell 166:1471-1484.e18|
|Ingale, Jidnyasa; Stano, Armando; Guenaga, Javier et al. (2016) High-Density Array of Well-Ordered HIV-1 Spikes on Synthetic Liposomal Nanoparticles Efficiently Activate B Cells. Cell Rep 15:1986-99|
|Chen, Yajing; Wilson, Richard; O'Dell, Sijy et al. (2016) An HIV-1 Env-Antibody Complex Focuses Antibody Responses to Conserved Neutralizing Epitopes. J Immunol 197:3982-3998|
|Wang, Yimeng; Sundling, Christopher; Wilson, Richard et al. (2016) High-Resolution Longitudinal Study of HIV-1 Env Vaccine-Elicited B Cell Responses to the Virus Primary Receptor Binding Site Reveals Affinity Maturation and Clonal Persistence. J Immunol 196:3729-43|
|Schramm, Chaim A; Sheng, Zizhang; Zhang, Zhenhai et al. (2016) SONAR: A High-Throughput Pipeline for Inferring Antibody Ontogenies from Longitudinal Sequencing of B Cell Transcripts. Front Immunol 7:372|
|Dai, Kaifan; Khan, Salar N; Wang, Yimeng et al. (2016) HIV-1 Vaccine-elicited Antibodies Reverted to Their Inferred Naive Germline Reveal Associations between Binding Affinity and in vivo Activation. Sci Rep 6:20987|
|Phad, Ganesh E; VÃ¡zquez Bernat, NÃ©stor; Feng, Yu et al. (2015) Diverse antibody genetic and recognition properties revealed following HIV-1 envelope glycoprotein immunization. J Immunol 194:5903-14|
Showing the most recent 10 out of 17 publications